Failure of benefit and early hazard of bucindolol for Class IV heart failure.
Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, Murray DR, Mann DL, Massie BM, McNamara DM, Oren R, Rogers WJ; Beta-Blocker Evaluation of Survival Trial (BEST) Investigators.
Anderson JL, et al. Among authors: hager wd.
J Card Fail. 2003 Aug;9(4):266-77. doi: 10.1054/jcaf.2003.42.
J Card Fail. 2003.
PMID: 13680547
Clinical Trial.